Drug Search Results
More Filters [+]

Clodronic acid

Alternative Names: clodronic acid, clodronate, bonefos
Latest Update: 2024-08-15
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Osteoclast Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Australia | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Croatia | Czech | Dominican Republic | Egypt | Finland | France | Germany | Greece | Hong Kong | Hungary | Indonesia | Ireland | Israel | Italy | Jordan | Malta | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Slovenia | Spain | Sweden | Taiwan | Thailand | Tunisia | Turkey | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Elanco Animal Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Clodronic acid

Countries in Clinic: Italy

Active Clinical Trial Count: 3

Highest Development Phases

Phase 3: Osteoarthritis, Knee

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SPA-S-899-01-21

P3

Not yet recruiting

Osteoarthritis, Knee

2025-10-01

SPA-S-899-01-21

P3

Recruiting

Osteoarthritis, Knee

2025-07-01

SPA-S-899-01-21

P3

Active, not recruiting

Osteoarthritis, Knee

2025-05-15

Recent News Events